Cargando…
Strategies for vaccine-product innovation: Creating an enabling environment for product development to uptake in low- and middle-income countries
Vaccine-product innovations that address barriers to immunization are urgently needed to achieve equitable vaccine coverage, as articulated in the new Immunization Agenda 2030 and the Gavi 5.0 strategy. In 2020, the Vaccine Innovation Prioritisation Strategy (VIPS) prioritized three innovations, nam...
Autores principales: | Giersing, Birgitte, Shah, Natasha, Kristensen, Debra, Amorij, Jean-Pierre, Kahn, Anna-Lea, Gandrup-Marino, Kristoffer, Jarrahian, Courtney, Zehrung, Darin, Menozzi-Arnaud, Marion |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Science
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8657812/ https://www.ncbi.nlm.nih.gov/pubmed/34627624 http://dx.doi.org/10.1016/j.vaccine.2021.07.091 |
Ejemplares similares
-
A global collaboration to advance vaccine product innovations – The Vaccine Innovation Prioritisation Strategy
por: Kristensen, Debra, et al.
Publicado: (2021) -
Exploring potential applications of measles and rubella microarray patches (MR-MAPs): use case identification
por: Malvolti, Stefano, et al.
Publicado: (2023) -
Vaccine innovation prioritisation strategy: Findings from three country-stakeholder consultations on vaccine product innovations
por: Mvundura, Mercy, et al.
Publicado: (2021) -
Accelerating the Development of Measles and Rubella Microarray Patches to Eliminate Measles and Rubella: Recent Progress, Remaining Challenges
por: Hasso-Agopsowicz, Mateusz, et al.
Publicado: (2022) -
Evaluating the cost per child vaccinated with full versus fractional-dose inactivated poliovirus vaccine
por: Mvundura, Mercy, et al.
Publicado: (2019)